8-K Announcements
6Material company update
Apr 9, 2026·SEC
Material company update
Apr 3, 2026·SEC
Material company update
Feb 26, 2026·SEC
Definitive Healthcare Corp.(DH)Earnings, Financials & Key Ratios
DH•NASDAQ
$0.95
$99M mkt cap·Price updated May 6, 2026
AboutDefinitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Show more
- Revenue$242M-4.2%
- EBITDA$15M+102.3%
- Net Income-$139M+66.4%
- EPS (Diluted)-1.30+63.3%
- Gross Margin75.88%-3.1%
- EBITDA Margin6.31%+102.4%
- Operating Margin-8.52%+97.0%
- Net Margin-57.52%+64.9%
- ROE-28.18%+38.4%
- ROIC-2.69%+94.7%
- Debt/Equity0.47+12.6%
- Interest Coverage-17.54+58.0%
DH Key Insights
Definitive Healthcare Corp. (DH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FCF machine: 15.3% free cash flow margin
- ✓Strong 5Y sales CAGR of 15.3%
- ✓Healthy dividend yield of 3.1%
- ✓Share count reduced 8.6% through buybacks
- ✓Trading at only 0.3x book value
✗Weaknesses
- ✗Profits declining 21.4% over 5 years
- ✗Weak momentum: RS Rating 5 (bottom 5%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
DH Price & Volume
Definitive Healthcare Corp. (DH) stock price & volume — 10-year historical chart
Loading chart...
DH Growth Metrics
Definitive Healthcare Corp. (DH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years15.34%
3 Years2.75%
TTM-4.24%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM66.37%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM64.48%
Return on Capital
10 Years-11.53%
5 Years-15.92%
3 Years-25.3%
Last Year-2.73%
DH Recent Earnings
Definitive Healthcare Corp. (DH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 26, 2026EPS
$0.06
Est $0.06
+0.0%
Revenue
$62M
Est $60M
+3.2%
Q4 2025
Nov 6, 2025EPS
$0.07
Est $0.06
+16.7%
Revenue
$60M
Est $60M
+0.8%
Q3 2025
Aug 7, 2025EPS
$0.07
Est $0.05
+40.0%
Revenue
$61M
Est $59M
+2.6%
Q2 2025
May 8, 2025EPS
$0.05
Est $0.02
+150.0%
Revenue
$59M
Est $58M
+1.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.06vs $0.06+0.0% | $62Mvs $60M+3.2% |
| Q4 2025 | Nov 6, 2025 | $0.07vs $0.06+16.7% | $60Mvs $60M+0.8% |
| Q3 2025 | Aug 7, 2025 | $0.07vs $0.05+40.0% | $61Mvs $59M+2.6% |
| Q2 2025 | May 8, 2025 | $0.05vs $0.02+150.0% | $59Mvs $58M+1.7% |
Based on last 12 quarters of dataView full earnings history →
DH Peer Comparison
Definitive Healthcare Corp. (DH) competitors in Healthcare Data, Analytics and AI — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 VEEV | 27.2B | 167.29 | 30.75 | 16.34% | 28.44% | 13.41% | 0.01 | |
 MMSI | 3.68B | 61.63 | 28.93 | 11.66% | 9.03% | 8.95% | 0.57 | |
 DOCS | 5.17B | 25.69 | 23.14 | 19.98% | 37.54% | 24.45% | 0.01 | |
 HCAT | 111.47M | 1.57 | -0.62 | 1.48% | -57.2% | -54.67% | 0.08 | |
 PINC | 2.34B | 28.26 | 128.45 | -10.86% | -2.42% | -1.59% | 0.18 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 SDGR | 969.87M | 12.98 | -9.21 | 23.29% | -40.6% | -30.85% | 0.30 | |
 CRM | 174.3B | 181.19 | 23.23 | 9.58% | 17.96% | 12.61% | 0.11 |
Compare DH vs Peers
Definitive Healthcare Corp. (DH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DH Income Statement
Definitive Healthcare Corp. (DH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 85.5M | 118.32M | 166.15M | 222.65M | 251.41M | 252.2M | 241.52M |
| Revenue Growth % | - | 38.38% | 40.43% | 34% | 12.92% | 0.31% | -4.24% |
| Cost of Goods Sold | 43.04M | 30.47M | 40.69M | 42.63M | 47.48M | 54.73M | 58.25M |
| COGS % of Revenue | 50.33% | 25.75% | 24.49% | 19.14% | 18.89% | 21.7% | 24.12% |
| Gross Profit | 42.47M▲ 0% | 87.85M▲ 106.9% | 125.47M▲ 42.8% | 180.03M▲ 43.5% | 203.93M▲ 13.3% | 197.47M▼ 3.2% | 183.28M▼ 7.2% |
| Gross Margin % | 49.67% | 74.25% | 75.51% | 80.86% | 81.11% | 78.3% | 75.88% |
| Gross Profit Growth % | - | 106.86% | 42.82% | 43.49% | 13.28% | -3.17% | -7.19% |
| Operating Expenses | 44.64M | 103.73M | 152.78M | 224.07M | 533.73M | 908.29M | 203.86M |
| OpEx % of Revenue | 52.21% | 87.68% | 91.95% | 100.64% | 212.29% | 360.14% | 84.41% |
| Selling, General & Admin | 37.2M | 48.7M | 89.25M | 141.15M | 153.4M | 133.07M | 133.26M |
| SG&A % of Revenue | 43.5% | 41.16% | 53.72% | 63.39% | 61.01% | 52.76% | 55.18% |
| Research & Development | 7.45M | 11.06M | 18.57M | 34.89M | 42.44M | 36.52M | 34.78M |
| R&D % of Revenue | 8.71% | 9.35% | 11.17% | 15.67% | 16.88% | 14.48% | 14.4% |
| Other Operating Expenses | 0 | 43.97M | 44.97M | 48.03M | 337.9M | 738.7M | 35.82M |
| Operating Income | -2.17M▲ 0% | -15.89M▼ 630.4% | -27.32M▼ 72.0% | -44.04M▼ 61.2% | -329.8M▼ 648.8% | -710.82M▼ 115.5% | -20.58M▲ 97.1% |
| Operating Margin % | -2.54% | -13.43% | -16.44% | -19.78% | -131.18% | -281.85% | -8.52% |
| Operating Income Growth % | - | -630.39% | -71.96% | -61.23% | -648.81% | -115.53% | 97.1% |
| EBITDA | 31.36M | 43.7M | 32.63M | 12.86M | -278.05M | -659.15M | 15.23M |
| EBITDA Margin % | 36.68% | 36.93% | 19.64% | 5.78% | -110.59% | -261.36% | 6.31% |
| EBITDA Growth % | - | 39.32% | -25.32% | -60.59% | -2261.96% | -137.06% | 102.31% |
| D&A (Non-Cash Add-back) | 33.54M | 59.58M | 59.95M | 56.9M | 51.75M | 51.67M | 35.82M |
| EBIT | -18.03M | -16.11M | -36.87M | -30.68M | -292.98M | -618.91M | -197.97M |
| Net Interest Income | 0 | -36.49M | -25.87M | -8.41M | -1.56M | -245K | -4.34M |
| Interest Income | 18.37M | 0 | 29K | 2.79M | 13.64M | 14.59M | 6.95M |
| Interest Expense | 18.37M | 36.49M | 25.9M | 11.2M | 15.2M | 14.84M | 11.29M |
| Other Income/Expense | -34.22M | -36.71M | -35.45M | 2.17M | 21.62M | 77.08M | -188.67M |
| Pretax Income | -36.4M▲ 0% | -52.6M▼ 44.5% | -62.77M▼ 19.3% | -41.88M▲ 33.3% | -308.18M▼ 635.9% | -633.75M▼ 105.6% | -209.26M▲ 67.0% |
| Pretax Margin % | -42.57% | -44.46% | -37.78% | -18.81% | -122.58% | -251.28% | -86.64% |
| Income Tax | 0 | 0 | -443K | -17.7M | -18.55M | -42.3M | -9.96M |
| Effective Tax Rate % | 0% | 0% | 0.71% | 42.26% | 6.02% | 6.67% | 4.76% |
| Net Income | -36.4M▲ 0% | -52.6M▼ 44.5% | -51.91M▲ 1.3% | -7.22M▲ 86.1% | -202.39M▼ 2702.4% | -413.12M▼ 104.1% | -138.93M▲ 66.4% |
| Net Margin % | -42.57% | -44.46% | -31.24% | -3.24% | -80.5% | -163.81% | -57.52% |
| Net Income Growth % | - | -44.51% | 1.31% | 86.09% | -2702.38% | -104.12% | 66.37% |
| Net Income (Continuing) | -36.4M | -52.6M | -62.32M | -24.18M | -289.63M | -591.45M | -199.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 628.52M | 533.03M | 337.82M | 162.82M | 97.88M |
| EPS (Diluted) | -0.24▲ 0% | -0.53▼ 120.8% | -0.19▲ 64.2% | -0.07▲ 62.4% | -1.79▼ 2407.0% | -3.54▼ 97.8% | -1.30▲ 63.3% |
| EPS Growth % | - | -120.83% | 64.15% | 62.42% | -2407% | -97.77% | 63.28% |
| EPS (Basic) | -0.24 | -0.53 | -0.19 | -0.07 | -1.79 | -3.54 | -1.30 |
| Diluted Shares Outstanding | 149.1M | 97.03M | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
| Basic Shares Outstanding | 149.1M | 97.03M | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
DH Balance Sheet
Definitive Healthcare Corp. (DH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 36.11M | 63.84M | 444.23M | 413.75M | 380.44M | 370.17M | 257.61M |
| Cash & Short-Term Investments | 8.62M | 24.77M | 387.5M | 331.87M | 308.07M | 290.16M | 180.89M |
| Cash Only | 8.62M | 24.77M | 387.5M | 146.93M | 130.98M | 105.38M | 163.63M |
| Short-Term Investments | 0 | 0 | 0 | 184.94M | 177.09M | 184.79M | 17.26M |
| Accounts Receivable | 25.02M | 33.11M | 43.34M | 58.8M | 59.25M | 53.23M | 51.98M |
| Days Sales Outstanding | 106.81 | 102.14 | 95.2 | 96.39 | 86.02 | 77.04 | 78.55 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - |
| Other Current Assets | 769K | 2.95M | 6.88M | 23.07M | 13.12M | 26.78M | 24.74M |
| Total Non-Current Assets | 1.69B | 1.68B | 1.67B | 1.71B | 1.43B | 719.22M | 477.89M |
| Property, Plant & Equipment | 2.56M | 3.25M | 5.07M | 14.14M | 14.06M | 11.31M | 18.07M |
| Fixed Asset Turnover | 33.43x | 36.43x | 32.78x | 15.74x | 17.88x | 22.30x | 13.36x |
| Goodwill | 1.23B | 1.26B | 1.26B | 1.32B | 1.08B | 393.28M | 197.22M |
| Intangible Assets | 446.38M | 410.24M | 352.47M | 350.72M | 323.12M | 297.93M | 247.48M |
| Long-Term Investments | 0 | 5.95M | 32.67M | 0 | 509K | 0 | 0 |
| Other Non-Current Assets | 2.72M | 472K | 19.94M | 19.28M | 19.2M | 16.69M | 15.12M |
| Total Assets | 1.72B▲ 0% | 1.75B▲ 1.4% | 2.12B▲ 21.3% | 2.12B▲ 0.2% | 1.83B▼ 14.0% | 1.09B▼ 40.3% | 735.49M▼ 32.5% |
| Asset Turnover | 0.05x | 0.07x | 0.08x | 0.10x | 0.14x | 0.23x | 0.33x |
| Asset Growth % | - | 1.41% | 21.33% | 0.24% | -13.98% | -40.34% | -32.49% |
| Total Current Liabilities | 69.92M | 88.72M | 123.12M | 140.61M | 170.68M | 161.16M | 156.79M |
| Accounts Payable | 2.16M | 5.66M | 4.65M | 3.95M | 5.79M | 10.76M | 3.6M |
| Days Payables Outstanding | 18.29 | 67.83 | 41.72 | 33.81 | 44.49 | 71.78 | 22.53 |
| Short-Term Debt | 4.5M | 4.68M | 6.88M | 8.59M | 13.75M | 13.75M | 11.43M |
| Deferred Revenue (Current) | 45.98M | 61.64M | 83.61M | 99.69M | 97.38M | 93.34M | 96.99M |
| Other Current Liabilities | 338K | 2.08M | 2.97M | 3.16M | 38.72M | 25.21M | 44.77M |
| Current Ratio | 0.52x | 0.72x | 3.61x | 2.94x | 2.23x | 2.30x | 1.64x |
| Quick Ratio | 0.52x | 0.72x | 3.61x | 2.94x | 2.23x | 2.30x | 1.64x |
| Cash Conversion Cycle | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 435M | 461.07M | 494.66M | 500.07M | 456.05M | 321.03M | 199.71M |
| Long-Term Debt | 434.85M | 457.2M | 263.81M | 255.76M | 242.57M | 229.37M | 161.24M |
| Capital Lease Obligations | 0 | 0 | 0 | 9.97M | 9.37M | 7.59M | 5.15M |
| Deferred Tax Liabilities | 0 | 0 | 76.4M | 75.74M | 67.16M | 25.09M | 14.63M |
| Other Non-Current Liabilities | 0 | 3.74M | 154.04M | 158.36M | 136.93M | 58.96M | 16.31M |
| Total Liabilities | 504.91M | 549.8M | 617.78M | 640.68M | 626.73M | 482.19M | 356.5M |
| Total Debt | 439.35M | 461.88M | 270.68M | 275.85M | 267.93M | 253.11M | 177.82M |
| Net Debt | 430.73M | 437.1M | -116.81M | 128.91M | 136.95M | 147.73M | 14.19M |
| Debt / Equity | 0.36x | 0.39x | 0.18x | 0.19x | 0.22x | 0.42x | 0.47x |
| Debt / EBITDA | 14.01x | 10.57x | 8.30x | 21.45x | - | - | 11.67x |
| Net Debt / EBITDA | 13.73x | 10.00x | -3.58x | 10.02x | - | - | 0.93x |
| Interest Coverage | -0.98x | -0.44x | -1.42x | -2.74x | -19.27x | -41.71x | -17.54x |
| Total Equity | 1.22B▲ 0% | 1.2B▼ 1.7% | 1.5B▲ 25.5% | 1.48B▼ 1.2% | 1.2B▼ 19.1% | 607.19M▼ 49.4% | 378.99M▼ 37.6% |
| Equity Growth % | - | -1.7% | 25.45% | -1.19% | -19.08% | -49.37% | -37.58% |
| Book Value per Share | 8.16 | 12.32 | 15.46 | 14.66 | 10.63 | 5.21 | 3.55 |
| Total Shareholders' Equity | 1.22B | 1.2B | 871.31M | 948.92M | 861.36M | 444.38M | 281.11M |
| Common Stock | 1.27B | 1.31B | 97K | 105K | 117K | 114K | 104K |
| Retained Earnings | -55.76M | -109.86M | -17.84M | -25.06M | -227.45M | -640.57M | -779.51M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -131K | 62K | 3.67M | 2.11M | -610K | -1.45M |
| Minority Interest | 0 | 0 | 628.52M | 533.03M | 337.82M | 162.82M | 97.88M |
DH Cash Flow Statement
Definitive Healthcare Corp. (DH) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|
| Cash from Operations | 21.59M | 23.22M | 25.21M | 35.58M | 41.19M | 58.2M | 53.78M |
| Operating CF Margin % | 25.26% | 19.62% | 15.17% | 15.98% | 16.38% | 23.08% | 22.27% |
| Operating CF Growth % | - | 7.52% | 8.59% | 41.12% | 15.77% | 41.29% | -7.59% |
| Net Income | -36.4M | -52.6M | -62.32M | -22.25M | -202.39M | -591.45M | -199.3M |
| Depreciation & Amortization | 33.54M | 59.58M | 59.95M | 56.9M | 51.75M | 51.67M | 56.11M |
| Stock-Based Compensation | 0 | 1.75M | 9.96M | 36.43M | 48.74M | 38.09M | 29.14M |
| Deferred Taxes | 0 | 0 | -587K | -26.67M | -18.71M | -119.58M | -10.88M |
| Other Non-Cash Items | 12.02M | 14.63M | 20.73M | 13.12M | 192.19M | 705.4M | 188.12M |
| Working Capital Changes | 12.43M | -147K | -2.51M | -21.95M | -30.39M | -25.93M | -9.42M |
| Change in Receivables | -8.62M | -8.29M | -10.73M | -13.22M | 811K | 5.69M | 1.38M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 7.95M | 4.44M | 3.42M | 358K | 1.33M | -5.46M | -1.09M |
| Cash from Investing | -1.14B | -23.86M | -46.73M | -248.9M | -31.78M | -26.41M | 153.88M |
| Capital Expenditures | -1.9M | -1.4M | -6.73M | -8.33M | -2.98M | -12.34M | -16.72M |
| CapEx % of Revenue | 2.22% | 1.18% | 4.05% | 3.74% | 1.18% | 4.89% | 6.92% |
| Acquisitions | -1.14B | -22.47M | -40M | -56.3M | -45.02M | -13.53M | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.12B | 16.66M | 384.37M | -26.7M | -25.58M | -56.75M | -150.79M |
| Debt Issued (Net) | 434.62M | 13.46M | -199.46M | -6.88M | -8.59M | -13.75M | -79.47M |
| Equity Issued (Net) | 696.99M | 0 | 603.18M | -1.73M | -30K | -22.37M | -49.45M |
| Dividends Paid | -6.96M | -2.94M | -8.13M | -12.87M | -12.28M | -5.13M | -3.15M |
| Share Repurchases | 0 | 0 | -231.77M | 0 | 0 | -22.37M | -49.45M |
| Other Financing | 0 | 6.14M | -11.22M | -5.22M | -4.68M | -15.5M | -18.71M |
| Net Change in Cash | 8.62M▲ 0% | 16.16M▲ 87.5% | 362.72M▲ 2145.1% | -240.56M▼ 166.3% | -15.96M▲ 93.4% | -25.6M▼ 60.4% | 58.25M▲ 327.6% |
| Free Cash Flow | 19.69M▲ 0% | 21.82M▲ 10.8% | 18.48M▼ 15.3% | 27.25M▲ 47.5% | 38.21M▲ 40.2% | 45.85M▲ 20.0% | 37.06M▼ 19.2% |
| FCF Margin % | 23.03% | 18.44% | 11.12% | 12.24% | 15.2% | 18.18% | 15.34% |
| FCF Growth % | - | 10.81% | -15.31% | 47.47% | 40.22% | 19.99% | -19.18% |
| FCF per Share | 0.13 | 0.22 | 0.19 | 0.27 | 0.34 | 0.39 | 0.35 |
| FCF Conversion (FCF/Net Income) | -0.59x | -0.44x | -0.49x | -4.93x | -0.20x | -0.14x | -0.39x |
| Interest Paid | 0 | 25.96M | 29.57M | 0 | 14.46M | 0 | 0 |
| Taxes Paid | 0 | 0 | 13K | 0 | 136K | 0 | 0 |
DH Key Ratios
Definitive Healthcare Corp. (DH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -2.99% | -4.36% | -3.85% | -0.48% | -15.1% | -45.74% | -28.18% |
| Return on Invested Capital (ROIC) | - | -0.73% | -1.36% | -2.21% | -16.79% | -50.99% | -2.69% |
| Gross Margin | 49.67% | 74.25% | 75.51% | 80.86% | 81.11% | 78.3% | 75.88% |
| Net Margin | -42.57% | -44.46% | -31.24% | -3.24% | -80.5% | -163.81% | -57.52% |
| Debt / Equity | 0.36x | 0.39x | 0.18x | 0.19x | 0.22x | 0.42x | 0.47x |
| Interest Coverage | -0.98x | -0.44x | -1.42x | -2.74x | -19.27x | -41.71x | -17.54x |
| FCF Conversion | -0.59x | -0.44x | -0.49x | -4.93x | -0.20x | -0.14x | -0.39x |
| Revenue Growth | - | 38.38% | 40.43% | 34% | 12.92% | 0.31% | -4.24% |
DH SEC Filings & Documents
Definitive Healthcare Corp. (DH) SEC filings — annual & quarterly reports (10-K, 10-Q)
DH Frequently Asked Questions
Definitive Healthcare Corp. (DH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Definitive Healthcare Corp. (DH) reported $241.5M in revenue for fiscal year 2025. This represents a 182% increase from $85.5M in 2019.
Definitive Healthcare Corp. (DH) saw revenue decline by 4.2% over the past year.
Definitive Healthcare Corp. (DH) reported a net loss of $138.9M for fiscal year 2025.
Dividend & Returns
Yes, Definitive Healthcare Corp. (DH) pays a dividend with a yield of 3.12%. This makes it attractive for income-focused investors.
Definitive Healthcare Corp. (DH) has a return on equity (ROE) of -28.2%. Negative ROE indicates the company is unprofitable.
Definitive Healthcare Corp. (DH) generated $47.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More DH
Definitive Healthcare Corp. (DH) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates